Is HIV a model of accelerated or accentuated aging?

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 69, Issue 7, 2014, Pages 833-842

  Pathai, Sophia ^a   Bajillan, Hendren ^b   Landay, Alan L ^c,d   High, Kevin P ^e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b WG (Bill) Hefner Medical Center   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UTRECHT UNIVERSITY   (Netherlands)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Biomarkers of aging; HIV; Immunosenescence; Multimorbidity

Indexed keywords

BIOLOGICAL MARKER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGING; BIOLOGICAL MODEL; BIOMARKERS OF AGING; COMORBIDITY; CYTOMEGALOVIRUS INFECTION; DIGESTIVE SYSTEM; EYE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; IMMUNOSENESCENCE; MICROBIOLOGY; MULTIMORBIDITY; PATHOLOGY; PATHOPHYSIOLOGY; PREMATURE AGING; REVIEW; T LYMPHOCYTE;

AIDS; BIOMARKERS OF AGING; HIV; IMMUNOSENESCENCE; MULTIMORBIDITY;

AGING; AGING, PREMATURE; BIOLOGICAL MARKERS; COMORBIDITY; CYTOMEGALOVIRUS INFECTIONS; DIGESTIVE SYSTEM; EYE; HIV INFECTIONS; HUMANS; MODELS, BIOLOGICAL; T-LYMPHOCYTES;

EID: 84902246367     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glt168     Document Type: Review

References (99)

1. Antiretroviral Therapy Cohort C. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: A collaborative analysis of 14 cohort studies. Lancet. 2008;372:293-299
2. CDC. HIV/AIDS among persons aged 50 or over. http://www.cdc. gov/hiv/surveillance/resources/reports/2005report/. 2010
3. Negin J, Cumming RG. HIV infection in older adults in sub-Saharan Africa: Extrapolating prevalence from existing data. Bull World Health Organ. 2010;88:847-853. doi:10.2471/BLT.10.076349
4. Hontelez JA, Lurie MN, Newell ML, et al. Ageing with HIV in South Africa. AIDS. 2011;25:1665-1667. doi:10.1097/ QAD.0b013e32834982ea
5. Liu H, Lin X, Xu Y, Chen S, Shi J, Morisky D. Emerging HIV epidemic among older adults in Nanning, China. AIDS Patient Care STDS. 2012;26:565-567. doi:10.1089/apc.2012.0227
6. Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53:1120-1126. doi:10.1093/cid/cir627
7. Effros RB, Fletcher CV, Gebo K, et al. Aging and infectious diseases: Workshop on HIV infection and aging: What is known and future research directions. Clin Infect Dis. 2008;47:542-553. doi:10.1086/590150
8. Goulet JL, Fultz SL, Rimland D, et al. Aging and infectious diseases: Do patterns of comorbidity vary by HIV status, age, and HIV severity?. Clin Infect Dis. 2007;45:1593-1601. doi:10.1086/523577 (Pubitemid 351411845
9. Kim DJ, Westfall AO, Chamot E, et al. Multimorbidity patterns in HIV-infected patients: The role of obesity in chronic disease clustering. J Acquir Immune Defic Syndr. 2012;61:600-605. doi:10.1097/ QAI.0b013e31827303d5
10. El-Sadr WM, Lundgren JD, Neaton JD, et al. CD4+ countguided interruption of antiretroviral treatment. N Engl J Med. 2006;355:2283-2296. (Pubitemid 44837777
11. Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ. 2009;338:a3172. doi:0.1136/bmj.a3172
12. Kuller LH, Tracy R, Belloso W, et al.; INSIGHT SMART Study Group. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5:e203. doi:10.1371/ journal.pmed.0050203
13. Deeks SG. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med. 2009;17:118-123
14. Rickerts V, Brodt H, Staszewski S, Stille W. Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: The Frankfurt HIV-cohort study. Eur J Med Res. 2000;5:329-333
15. Salter ML, Lau B, Go VF, Mehta SH, Kirk GD. HIV infection, immune suppression, and uncontrolled viremia are associated with increased multimorbidity among aging injection drug users. Clin Infect Dis. 2011;53:1256-1264. doi:10.1093/cid/cir673
16. Hasse B, Ledergerber B, Furrer H, et al.; Swiss HIV Cohort Study. Morbidity and aging in HIV-infected persons: The Swiss HIV cohort study. Clin Infect Dis. 2011;53:1130-1139. doi:10.1093/ cid/cir626
17. Desquilbet L, Jacobson LP, Fried LP, et al.; Multicenter AIDS Cohort Study. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci. 2007;62:1279-1286. (Pubitemid 350287617
18. Erlandson KM, Allshouse AA, Jankowski CM, et al. Risk factors for falls in HIV-infected persons. J Acquir Immune Defic Syndr. 2012;61:484-489. doi:10.1097/QAI.0b013e3182716e38
19. High KP, Brennan-Ing M, Clifford DB, et al.; OAR Working Group on HIV and Aging. HIV and aging: State of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012;60(suppl 1):S1-18. doi:10.1097/QAI.0b013e31825a3668
20. Martin J, Volberding P. HIV and premature aging: A field still in its infancy. Ann Intern Med. 2010;153:477-479. doi:10.7326/0003-4819-153-7- 201010050-00013
21. Laprise C, Baril JG, Dufresne S, Trottier H. Association between tenofovir exposure and reduced kidney function in a cohort of HIVpositive patients: Results from 10 years of follow-up. Clin Infect Dis. 2013;56:567-575. doi:10.1093/cid/cis937
22. Scherzer R, Estrella M, Li Y, et al. Association of tenofovir exposure with kidney disease risk in HIV infection. AIDS. 2012;26:867-875. doi:10.1097/QAD.0b013e328351f68f
23. Hall AM, Hendry BM, Nitsch D, Connolly JO. Tenofovir-Associated kidney toxicity in HIV-infected patients: A review of the evidence. Am J Kidney Dis. 2011;57:773-780. doi:10.1053/j.ajkd.2011.01.022
24. Leeansyah E, Cameron PU, Solomon A, et al. Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: A potential factor contributing to HIV-Associated accelerated aging. J Infect Dis. 2013;207:1157-1165. doi:10.1093/infdis/jit006
25. Fisher M, Cooper V. HIV and ageing: Premature ageing or premature conclusions?. Curr Opin Infect Dis. 2012;25:1-3. doi:10.1097/ QCO.0b013e32834f14fa
26. Capeau J. Premature aging and premature age-related comorbidities in HIV-infected patients: Facts and hypotheses. Clin Infect Dis. 2011;53:1127-1129. doi:10.1093/cid/cir628
27. Armah KA, McGinnis K, Baker J, et al. HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis. 2012;55:126-136. doi:10.1093/ cid/cis406
28. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92:2506-2512. (Pubitemid 47037350
29. Guaraldi G, Zona S, Alexopoulos N, et al. Coronary aging in HIV-infected patients. Clin Infect Dis. 2009;49:1756-1762. doi:10.1086/648080
30. Martinez E, Mocroft A, García-Viejo MA, et al. Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: A prospective cohort study. Lancet. 2001;357:592-598. (Pubitemid 32179612
31. Wand H, Calmy A, Carey DL, et al.; INITIO Trial International Coordinating Committee. Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. AIDS. 2007;21:2445-2453
32. Cerrato E, D'Ascenzo F, Biondi-Zoccai G, et al. Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: A meta-Analysis in the highly active antiretroviral therapy era. Eur Heart J. 2013;34:1432-1436. doi:10.1093/eurheartj/ehs471
33. Papita A, Albu A, Fodor D, Itu C, Cârstina D. Arterial stiffness and carotid intima-media thickness in HIV infected patients. Med Ultrason. 2011;13:127-134
34. Seaberg EC, Benning L, Sharrett AR, et al. Association between human immunodeficiency virus infection and stiffness of the common carotid artery. Stroke. 2010;41:2163-2170. doi:10.1161/ STROKEAHA.110.583856
35. Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of renal disease among people living with HIV: A systematic review and meta-Analysis. BMC Public Health. 2012;12:234. doi:10.1186/1471-2458-12-234
36. Cazanave C, Dupon M, Lavignolle-Aurillac V, et al.; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. Reduced bone mineral density in HIV-infected patients: Prevalence and associated factors. AIDS. 2008;22:395-402. doi:10.1097/QAD.0b013e3282f423dd
37. Burgi A, Brodine S, Wegner S, et al. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer. 2005;104:1505-1511. (Pubitemid 41356166
38. Shiels MS, Pfeiffer RM, Engels EA. Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med. 2010;153:452-460. doi:10.7326/0003-4819-153-7-201010050-00008
39. J ustice AC, Freiberg MS, Tracy R, et al.; VACS Project Team. Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?. Clin Infect Dis. 2012;54:984-994. doi:10.1093/cid/cir989
40. Fried LP, Tangen CM, Walston J, et al.; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-M156
41. Bhavan KP, Kampalath VN, Overton ET. The aging of the HIV epidemic. Curr HIV/AIDS Rep. 2008;5:150-158
42. Shah K, Hilton TN, Myers L, Pinto JF, Luque AE, Hall WJ. A new frailty syndrome: Central obesity and frailty in older adults with the human immunodeficiency virus. J Am Geriatr Soc. 2012;60:545-549. doi:10.1111/j.1532- 5415.2011.03819.x
43. Leng S, Chaves P, Koenig K, Walston J. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: A pilot study. J Am Geriatr Soc. 2002;50:1268-1271. (Pubitemid 34774552
44. J anssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology. 1992;42:1472-1476
45. Cherner M, Ellis RJ, Lazzaretto D, et al.; HIV Neurobehavioral Research Center Group. Effects of HIV-1 infection and aging on neurobehavioral functioning: Preliminary findings. AIDS. 2004;18(suppl 1):S27-S34
46. McCutchan JA, Wu JW, Robertson K, et al. HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS. 2007;21:1109-1117. (Pubitemid 46763281
47. Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis. 1999;179: 859-870. (Pubitemid 29159331
48. Rodríguez B, Sethi AK, Cheruvu VK, et al. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA. 2006;296:1498-1506. (Pubitemid 44465514
49. Desai S, Landay A. Early immune senescence in HIV disease. Curr HIV/AIDS Rep. 2010;7:4-10. doi:10.1007/s11904-009-0038-4
50. Hunt PW, Brenchley J, Sinclair E, et al. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis. 2008;197:126-133. (Pubitemid 351263476
51. Brenchley JM, Paiardini M, Knox KS, et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood. 2008;112:2826-2835. doi:10.1182/blood-2008-05-159301
52. Lagathu C, Eustace B, Prot M, et al. Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages. Antivir Ther. 2007;12:489-500. (Pubitemid 47041147
53. Appay V, Almeida JR, Sauce D, Autran B, Papagno L. Accelerated immune senescence and HIV-1 infection. Exp Gerontol. 2007; 42:432-437. (Pubitemid 46561182
54. Pawelec G, Akbar A, Beverley P, et al. Immunosenescence and Cytomegalovirus: Where do we stand after a decade?. Immun Ageing. 2010;7:13. doi:10.1186/1742-4933-7-13
55. High KP, Akbar AN, Nikolich-Zugich J. Translational research in immune senescence: Assessing the relevance of current models. Semin Immunol. 2012;24:373-382. doi:10.1016/j.smim.2012.04.007
56. Czesnikiewicz-Guzik M, Lee WW, Cui D, et al. T cell subset-specific susceptibility to aging. Clin Immunol. 2008;127:107-118. doi:10.1016/j.clim. 2007.12.002
57. Vescovini R, Biasini C, Fagnoni FF, et al. Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects. J Immunol. 2007;179:4283-4291
58. Xie D, McElhaney JE. Lower GrB+ CD62Lhigh CD8 TCM effector lymphocyte response to influenza virus in older adults is associated with increased CD28null CD8 T lymphocytes. Mech Ageing Dev. 2007;128:392-400. (Pubitemid 47021190
59. Coppé JP, Desprez PY, Krtolica A, Campisi J. The senescence-Associated secretory phenotype: The dark side of tumor suppression. Annu Rev Pathol. 2010;5:99-118. doi:10.1146/annurev-pathol-121808-102144
60. Coppé JP, Rodier F, Patil CK, Freund A, Desprez PY, Campisi J. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. J Biol Chem. 2011;286:36396-36403. doi:10.1074/jbc.M111.257071
61. Onyema OO, Njemini R, Bautmans I, Renmans W, De Waele M, Mets T. Cellular aging and senescence characteristics of human T-lymphocytes. Biogerontology. 2012;13:169-181. doi:10.1007/ s10522-011-9366-z
62. Macaulay R, Akbar AN, Henson SM. The role of the T cell in agerelated inflammation. Age (Dordr). 2013;35:563-572. doi:10.1007/ s11357-012-9381-2
63. Desai SR, Usuga X, Martinson J. Immune senescence, activation, and abnormal T cell homeostasis despite effective HAART, a hallmark of early aging in HIV disease. Presented at: 16th Conference on Retroviruses and Opportunistic Infections; 2009; February 8-11, 2009; Montreal, Canada
64. Khan N, Shariff N, Cobbold M, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol. 2002;169:1984-1992. (Pubitemid 34857662
65. Looney RJ, Falsey A, Campbell D, et al. Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol. 1999;90:213-219. (Pubitemid 29162167
66. Tassiopoulos K, Landay A, Collier AC, et al. CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies. J Infect Dis. 2012;205:1730-1738. doi:10.1093/infdis/jis260
67. Cao W, Jamieson BD, Hultin LE, Hultin PM, Effros RB, Detels R. Premature aging of T cells is associated with faster HIV-1 disease progression. J Acquir Immune Defic Syndr. 2009;50:137-147. doi:10.1097/QAI.0b013e3181926c28
68. Kaplan RC, Sinclair E, Landay AL, et al. T cell activation and senescence predict subclinical carotid artery disease in HIVinfected women. J Infect Dis. 2011;203:452-463. doi:10.1093/ infdis/jiq071
69. Kaplan RC, Sinclair E, Landay AL, et al. T cell activation predicts carotid artery stiffness among HIV-infected women. Atherosclerosis. 2011;217:207-213. doi:10.1016/j.atherosclerosis.2011.03.011
70. Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004;200:749-759. (Pubitemid 39299461
71. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365-1371. doi:10.1016/j.tim.2012.09.001 (Pubitemid 44924494
72. Ipp H, Zemlin A. The paradox of the immune response in HIV infection: When inflammation becomes harmful. Clin Chim Acta. 2013;416:96-99. doi:10.1016/j.cca.2012.11.025
73. Martin GE, Gouillou M, Hearps AC, et al. Age-Associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women. PLoS One. 2013;8:e55279. doi:10.1371/journal. pone.0055279
74. Hearps AC, Maisa A, Cheng WJ, et al. HIV infection induces agerelated changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS. 2012;26:843-853. doi:10.1097/QAD.0b013e328351f756
75. Kelesidis T, Yang OO, Kendall MA, Hodis HN, Currier JS. Biomarkers of microbial translocation and macrophage activation are associated with progression of atherosclerosis in HIV infection: ACTG NWCS 332/A5078 study. Presented at: 19th Conference on Retroviruses and Opportunistic Infections; March 5-8, 2012; Seattle, W.A.
76. Manner I, Kvale D, Baekken M, et al. Microbial translocation independently predicts future hypertension in HIV-infected individuals. Presented at: 19th Conference on Retroviruses and Opportunistic Infections; 2012; March 5-8, 2012; Seattle, W.A.
77. Sandler NG, Wand H, Roque A, et al.; INSIGHT SMART Study Group. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203:780-790. doi:10.1093/infdis/jiq118
78. Pereyra F, Lo J, Triant VA, et al. Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers. AIDS. 2012;26:2409-2412. doi:10.1097/QAD.0b013e32835a9950
79. Lang DJ, Kovacs AA, Zaia JA, et al. Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study Group. J Acquir Immune Defic Syndr. 1989;2:540-549. (Pubitemid 20017257
80. Alonso Arias R, Moro-García MA, Echeverría A, Solano-Jaurrieta JJ, Suárez-García FM, López-Larrea C. Intensity of the humoral response to cytomegalovirus is associated with the phenotypic and functional status of the immune system. J Virol. 2013;87:4486-4495. doi:10.1128/JVI.02425-12
81. Naeger DM, Martin JN, Sinclair E, et al. Cytomegalovirus-specific T cells persist at very high levels during long-Term antiretroviral treatment of HIV disease. PLoS One. 2010;5:e8886. doi:10.1371/journal.pone.0008886
82. Parrinello CM, Sinclair E, Landay AL, et al. Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. J Infect Dis. 2012;205:1788-1796. doi:10.1093/infdis/ jis276
83. Hsue PY, Hunt PW, Sinclair E, et al. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS. 2006;20:2275-2283. (Pubitemid 44789529
84. Aiello AE, Simanek AM. Cytomegalovirus and immunological aging: The real driver of HIV and heart disease?. J Infect Dis. 2012;205:1772-1774. doi:10.1093/infdis/jis288
85. Nixon DE, Landay AL. Biomarkers of immune dysfunction in HIV. Curr Opin HIV AIDS. 2010;5:498-503. doi:10.1097/ COH.0b013e32833ed6f4
86. Deeks SG, Verdin E, McCune JM. Immunosenescence and HIV. Curr Opin Immunol. 2012;24:501-506. doi:10.1016/j.coi.2012.05.004
87. Baker GT 3rd, Sprott RL. Biomarkers of aging. Exp Gerontol. 1988;23:223-239
88. Lin J, Epel E, Cheon J, et al. Analyses and comparisons of telomerase activity and telomere length in human T and B cells: Insights for epidemiology of telomere maintenance. J Immunol Methods. 2010;352:71-80. doi:10.1016/j.jim. 2009.09.012
89. Effros RB, Allsopp R, Chiu CP, et al. Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS. 1996;10:F17-F22. (Pubitemid 26229506
90. Yamaguchi T, Takayama Y, Saito M, Ishikawa F, Saneyoshi M. Telomerase-inhibitory effects of the triphosphate derivatives of some biologically active nucleosides. Nucleic Acids Res Suppl. 2001:211-212
91. Peng Y, Mian IS, Lue NF. Analysis of telomerase processivity: Mechanistic similarity to HIV-1 reverse transcriptase and role in telomere maintenance. Mol Cell. 2001;7:1201-1211. (Pubitemid 32607354
92. Shiels PG. Improving precision in investigating aging: Why telomeres can cause problems. J Gerontol A Biol Sci Med Sci. 2010;65:789-791. doi:10.1093/gerona/glq095
93. Liu Y, Sanoff HK, Cho H, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009;8:439-448. doi:10.1111/j.1474-9726.2009.00489.x
94. Krishnamurthy J, Torrice C, Ramsey MR, et al. Ink4a/Arf expression is a biomarker of aging. J Clin Invest. 2004;114:1299-1307. (Pubitemid 40385301
95. Koppelstaetter C, Schratzberger G, Perco P, et al. Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell. 2008;7:491-497. doi:10.1111/j.1474-9726. 2008.00398.x (Pubitemid 351998609
96. Nelson JA, Krishnamurthy J, Menezes P, et al. Expression of p16(INK4a) as a biomarker of T-cell aging in HIV-infected patients prior to and during antiretroviral therapy. Aging Cell. 2012;11:916-918. doi:10.1111/j.1474-9726. 2012.00856.x
97. Pathai S, Lawn SD, Gilbert CE, et al. Accelerated biological ageing in HIV-infected individuals in South Africa: A case-control study. AIDS. 2013;27:2375-2384
98. Lundgren JD, Baxter J, Deeks SG, Lane HC. Biomarkers in HIV disease. Curr Opin HIV AIDS. 2010;5:459-462. doi:10.1097/ COH.0b013e32833f2ed6
99. Pathai S, Shiels PG, Lawn SD, Cook C, Gilbert C. The eye as a model of ageing in translational research-molecular, epigenetic and clinical aspects. Ageing Res Rev. 2013;12:490-508. doi:10.1016/j. arr.2012.11.002.